Kura Oncology Appoints Steven Stein, M.D. to Board of Directors
Jan 03, 2017 21:06 pm UTC| Business
LA JOLLA, Calif., Jan. 03, 2017 -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical stage biopharmaceutical company, today announced the appointment of Steven H. Stein, M.D., to its board of directors. Dr. Stein currently...
Kura Oncology Appoints Steven Stein, M.D. to Board of Directors
Jan 03, 2017 21:06 pm UTC| Business
LA JOLLA, Calif., Jan. 03, 2017 -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical stage biopharmaceutical company, today announced the appointment of Steven H. Stein, M.D., to its board of directors. Dr. Stein currently...
Global Blood Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 03, 2017 21:06 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2017 -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will present at the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017 at...
Global Blood Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 03, 2017 21:06 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2017 -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will present at the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017 at...
Points International to Present at the Needham Growth Conference
Jan 03, 2017 21:06 pm UTC| Business
TORONTO, Jan. 03, 2017 -- Points (TSX:PTS) (Nasdaq:PCOM), the global leader in powering loyalty commerce, today announced that its President, Christopher Barnard will present at the 19th Annual Needham Growth Conference...
Points International to Present at the Needham Growth Conference
Jan 03, 2017 21:06 pm UTC| Business
TORONTO, Jan. 03, 2017 -- Points (TSX:PTS) (Nasdaq:PCOM), the global leader in powering loyalty commerce, today announced that its President, Christopher Barnard will present at the 19th Annual Needham Growth Conference...
Spark Therapeutics to Participate in J.P. Morgan Healthcare Conference
Jan 03, 2017 21:06 pm UTC| Business
PHILADELPHIA, Jan. 03, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that Jeffrey D. Marrazzo, chief...